Gynuity Health Projects


Sublingual misoprostol vs oxytocin in women not exposed to oxytocin during labor

This article describes the results of a clinical trial seeking to evaluate the use of misoprostol compared to standard oxytocics for treatment of postpartum hemorrhage in women who were not previously exposed to oxytocin during labor. The results demonstrate that misoprostol may be a suitable first-line treatment alternative for this indication particularly in settings in which use of oxytocin is not feasible. Read the abstract at The Lancet (Jan 2010), Vol 375(9710), pp 210 – 216.

The "text only" version in this language is not currently available.

  • Topic: Postpartum Hemorrhage
  • Type: Staff Publication
  • Author: Winikoff, B., Dabash, R., Durocher, J., Darwish, E., Ngoc, N.T.N.,León, W., Raghavan, S., Medhat, I., Chi, H.T.K., Barrera, G., Blum, J.
  • Published: January 2010

Download PDF in English


Other Languages Available